Germany
Japan
United Kingdom
China
CD11a (ITGAL) mouse monoclonal antibody, clone DF1524, Aff - Purified
| Applications | FC, IF, IHC |
| Reactivities | Human |
Antibodies
View as table DownloadCD11a (ITGAL) mouse monoclonal antibody, clone DF1524, PE
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | PE |
CD11a (ITGAL) mouse monoclonal antibody, clone B-B15, Azide Free
| Applications | FC |
| Reactivities | Human |
CD11a (ITGAL) mouse monoclonal antibody, clone B-B15, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD11a (ITGAL) mouse monoclonal antibody, clone B-B15, Purified
| Applications | FC |
| Reactivities | Human |
CD11a (ITGAL) mouse monoclonal antibody, clone B-B15, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
Mouse Anti-Human CD11a Purified (100 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD11a (Clone MHM24)
| Applications | Inhib |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Target Symbol
- ITGAL
Antibody Hosts
- Mouse
Clonalities
- Monoclonal
Filter by
Category
Reactivities
Isotypes
Conjugates
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)